Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 16, 2015 - Issue 6
Submit an article Journal homepage
274
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Prognostic factors for survival following initiation of second-line treatment with everolimus for metastatic renal cell carcinoma: evidence from a nationwide sample of clinical practice in the United States

Michael K WongUniversity of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA
, MD PhD,
Eric JonaschAnderson Cancer Center, Houston, TX, USA
, MD,
Sumanta K PalCity of Hope Comprehensive Cancer Center, Duarte, CA, USA
, MD,
James E SignorovitchAnalysis Group, Inc., Boston, 111 Huntington Ave, 10th Floor, MA, USA+1 617 425 8475; +1 617 425 8001; [email protected]
, PhD,
Peggy L LinAnalysis Group, Inc., Boston, 111 Huntington Ave, 10th Floor, MA, USA+1 617 425 8475; +1 617 425 8001; [email protected]
, PhD,
Xufang WangNovartis Pharmaceuticals Corp., East Hanover, NJ, USA
,
Zhimei LiuNovartis Pharmaceuticals Corp., East Hanover, NJ, USA
, PhD,
Ken CulverNovartis Pharmaceuticals Corp., East Hanover, NJ, USA
, MD,
Jeffrey A ScottCardinal Health, Grand Prairie, TX, USA
, MD,
Daniel J GeorgeGU Oncology, Duke Cancer Institute, Durham, NC, USA
&
Nicholas J VogelzangUS Oncology Research, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA
, MD show all
Pages 805-819 | Published online: 12 Mar 2015

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

José Luis González-Larriba, Pablo Maroto, Ignacio Durán, Julio Lambea, Luis Flores, Daniel Castellano & the Changing Group. (2017) The role of mTOR inhibition as second-line therapy in metastatic renal carcinoma: clinical evidence and current challenges. Expert Review of Anticancer Therapy 17:3, pages 217-226.
Read now
Carlo Buonerba, Matteo Ferro, Francesco Perri, Giuseppe Calderoni, Pina Mambella, Pasqualina Giordano, Prisco Piscitelli, Vittorino Montanaro, Michele Aieta & Giuseppe Di Lorenzo. (2015) How can we improve prognostic models in renal cell carcinoma?. Expert Opinion on Pharmacotherapy 16:9, pages 1281-1283.
Read now

Articles from other publishers (4)

Jie Hu, Fei-Yu Chen, Kai-Qian Zhou, Cheng Zhou, Ya Cao, Hui-Chuan Sun, Jia Fan, Jian Zhou & Zheng Wang. (2017) Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection. Oncotarget 8:69, pages 113817-113827.
Crossref
Emiliano Calvo, Manuela Schmidinger, Daniel Y.C. Heng, Viktor Grünwald & Bernard Escudier. (2016) Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy. Cancer Treatment Reviews 50, pages 109-117.
Crossref
Sumanta K. Pal, James E. Signorovitch, William M. Reichmann, Nanxin Li, Valerie Koo, Zhimei Liu, Jose Ricardo Perez & Nicholas J. Vogelzang. (2016) Real-World Effectiveness of Everolimus Subsequent to Different First Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Synthesis of Retrospective Chart Reviews. Clinical Genitourinary Cancer 14:2, pages 160-167.e3.
Crossref
J.D. Rebibo, C. Pfister, A. Giwerc, G. Defortescu, S. Gouerant, F. Di Fiore & F.-X. Nouhaud. (2016) Étude des facteurs pronostiques pour le carcinome rénal métastatique traité par une deuxième ligne de thérapies ciblées. Progrès en Urologie 26:1, pages 16-23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.